Dark

CCXI
Churchill Capital Corp XI Class A
stock NASDAQ

At Close

Jul 16, 2026 3:59:55 PM EDT

14.60USD-7.274%(-1.14)3,084,838

12.51Bid 16.79Ask 4.28Spread

Pre-market

Jul 16, 2026 9:29:50 AM EDT

15.04USD-4.447%(-0.70)58,509

After-hours

Jul 16, 2026 4:45:30 PM EDT

14.80USD+1.405%(+0.20)3,634

Overview HistoricalExchangesShortsMore

open chart

Market Cap

812.94M

CEO

Thomas Schall

Headquarters

Mountain View, California, USA

Industry

Biotechnology

AMGN BIIB GSK BMY JNJ PFE MRK TEVA ABBV FBIO XLV

CCXI Stats

Avg. Vol. 10 Day

5,562,637

Avg. Vol. 30 Day

3,215,366

Employees

Market Cap

812,941,500

Shares Out.

55,700,000

On/Off Exchange

51%/49%

6 Month Beta

0.37

3 Year Beta

-0.23

52 Week Low

10.07

52 Week High

19.69

SMA50

11.87

SMA200

25.41

1 Week

-10.07%

1 Month

+42.42%

3 Month

+43.30%

6 Month

+42.25%

5 Year

-7.92%

Profile

ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx's lead drug candidate, avacopan (CCX168), successfully completed a pivotal Phase III trial in ANCA-associated vasculitis and a New Drug Application is under review by the U.S. Food and Drug Administration. Avacopan is also in late stage clinical development for the treatment of severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G). ChemoCentryx also has early stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.

CCXI Stock Summary

Churchill Capital Corp XI Class A (NASDAQ:CCXI) stock price today is $14.60, and today's volume is 3,084,838. CCXI is down -7.274% today. The 30 day average volume is 3,215,366. CCXI market cap is 812.94M with 55,700,000 shares outstanding.